VIGL logo

Vigil Neuroscience (VIGL)

Profile

Full Name

Vigil Neuroscience, Inc.

Ticker Symbol

VIGL

Exchange

NASDAQ

Country

United States

IPO

January 7, 2022

Indexes

Not included

Employees

69

Key Details

Price

$1.51(-2.58%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.07(+2.82% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 14, 25 Wedbush
Outperform
Mar 14, 25 HC Wainwright & Co.
Buy
Jan 24, 25 Guggenheim
Buy
Jan 23, 25 HC Wainwright & Co.
Buy
Dec 4, 24 William Blair
Outperform
Nov 26, 24 JMP Securities
Market Outperform
Nov 8, 24 Wedbush
Outperform
Nov 8, 24 HC Wainwright & Co.
Buy
Aug 14, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Guggenheim
Buy

Institutional Ownership

  • What is the ticker symbol for Vigil Neuroscience?
  • Does Vigil Neuroscience pay dividends?
  • What sector is Vigil Neuroscience in?
  • What industry is Vigil Neuroscience in?
  • What country is Vigil Neuroscience based in?
  • When did Vigil Neuroscience go public?
  • Is Vigil Neuroscience in the S&P 500?
  • Is Vigil Neuroscience in the NASDAQ 100?
  • Is Vigil Neuroscience in the Dow Jones?
  • When was Vigil Neuroscience's last earnings report?
  • When does Vigil Neuroscience report earnings?
  • Should I buy Vigil Neuroscience stock now?

What is the ticker symbol for Vigil Neuroscience?

The ticker symbol for Vigil Neuroscience is NASDAQ:VIGL

Does Vigil Neuroscience pay dividends?

No, Vigil Neuroscience does not pay dividends

What sector is Vigil Neuroscience in?

Vigil Neuroscience is in the Healthcare sector

What industry is Vigil Neuroscience in?

Vigil Neuroscience is in the Biotechnology industry

What country is Vigil Neuroscience based in?

Vigil Neuroscience is headquartered in United States

When did Vigil Neuroscience go public?

Vigil Neuroscience's initial public offering (IPO) was on January 7, 2022

Is Vigil Neuroscience in the S&P 500?

No, Vigil Neuroscience is not included in the S&P 500 index

Is Vigil Neuroscience in the NASDAQ 100?

No, Vigil Neuroscience is not included in the NASDAQ 100 index

Is Vigil Neuroscience in the Dow Jones?

No, Vigil Neuroscience is not included in the Dow Jones index

When was Vigil Neuroscience's last earnings report?

Vigil Neuroscience's most recent earnings report was on Mar 13, 2025

When does Vigil Neuroscience report earnings?

The next expected earnings date for Vigil Neuroscience is May 7, 2025

Should I buy Vigil Neuroscience stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page